Related Experiment Videos
[Immunophenotyping of haematologic malignancies]
S G A Koehorst1, H Evers, T van Buul
1Afd. Klinische Chemie, Slingeland Ziekenhuis, Doetinchem.
Nederlands Tijdschrift Voor Geneeskunde
|October 23, 2004
Summary
Immunophenotyping using monoclonal antibodies (MOABs) is now essential for diagnosing blood cancers, complementing traditional methods. This technique aids in accurate diagnosis, prognosis, and treatment selection for leukaemias and lymphomas.
Area of Science:
- Hematology
- Immunology
- Cell Biology
Context:
- Morphological analysis is the traditional method for diagnosing hematologic malignancies.
- Immunophenotyping has emerged as a crucial diagnostic tool over the past decade.
- Advancements in monoclonal antibodies (MOABs), fluorochromes, and flow cytometry have driven its routine clinical adoption.
Purpose:
- To classify leukaemias and malignant lymphomas based on cell type and maturation stage.
- To provide critical information for accurate diagnosis and prognosis.
- To guide optimal treatment strategies for hematologic malignancies.
Summary:
- Immunophenotyping utilizes fluorescently labeled monoclonal antibodies (MOABs) to identify specific cell surface structures.
- Flow cytometry and fluorescence microscopy are used to analyze cells labeled with MOABs.
- This method offers diagnostic insights beyond morphological examination, including the detection of minimal residual disease.
Impact:
- Enhances diagnostic accuracy and prognostic assessment of hematologic cancers.
- Facilitates personalized treatment selection for patients.
- Enables sensitive detection of minimal residual disease, crucial for monitoring remission and relapse.